Key result
Utilization of mechanical circulatory support for VT/VF in-hospital cardiac arrest increased from 8.7% to 11% between 2008 and 2014, with overall survival increasing from 35.4% to 43.5%.
Why the study?
Pulseless VT/VF is the initial rhythm in one-third of in-hospital cardiac arrest cases, but the use of mechanical circulatory support devices in this population remains poorly understood.
What are the temporal trends in the utilization of mechanical circulatory support and survival to discharge in patients with in-hospital cardiac arrest secondary to VT/VF?
Observational (n=151,628)
Yes
What are the temporal trends in the utilization of mechanical circulatory support and survival to discharge in patients with in-hospital cardiac arrest secondary to VT/VF?
Answers are grounded in this paper and cite their sources.
Between 2008 and 2014, both the utilization of mechanical circulatory support and overall survival to hospital discharge significantly increased among patients experiencing in-hospital cardiac arrest due to VT/VF.
Background Pulseless ventricular tachycardia/ventricular fibrillation (VT/VF) is the initial rhythm in a third of in‐hospital cardiac arrest patients. Mechanical circulatory support (MCS) device use remains poorly understood in this population. Methods We conducted an observational analysis of temporal trends in the utilization of MCS in VT/VF IHCA between January 2008 and December 2014 utilizing the Nationwide Inpatient Sample (NIS) database. Using multivariable analysis, we assessed factors associated with MCS use and survival to discharge. Results Among 151,628 hospitalizations with VT/VF IHCA, 14,981 (9.9%) received MCS. Intra‐aortic balloon pump (IABP) was the most commonly used MCS (9.1%). From 2008 to 2014, there was significant increase in the utilization of MCS (8.7–11%; ptrend < 0.0001). On multivariable analysis, there was 12‐fold increase and three‐fold increase in the utilization of PVAD and ECMO respectively; however, there was no significant change in the use of IABP. Over the seven‐year sample period, there was significant increase in the overall survival to hospital discharge (35.4–43.5%; ptrend < 0.0001). Survival to hospital discharge increased in both MCS and non‐MCS groups. Conclusion There was significant increase in utilization of MCS after VT/VF IHCA during the study period. IABP was the most commonly utilized MCS. The survival to hospital discharge increased in the overall study population including both MCS and non‐MCS groups. Future studies are needed to identify patient population most likely to benefit from the use of MCS after VT/VF IHCA.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2019) conducted an observational in In-hospital cardiac arrest secondary to ventricular tachycardia/ventricular fibrillation (n=151,628). Mechanical circulatory support (MCS) vs. No mechanical circulatory support was evaluated on Utilization of MCS and survival to hospital discharge (p=< 0.0001). Utilization of mechanical circulatory support for VT/VF in-hospital cardiac arrest increased from 8.7% to 11% between 2008 and 2014, with overall survival increasing from 35.4% to 43.5%.
Synapse has enriched 10 related papers. Consider them for comparative context: